# Intraoperative Radiation Therapy for Resectable Pancreas Cancer

> **NCT02599662** · PHASE1 · UNKNOWN · sponsor: **Loyola University** · enrollment: 12 (estimated)

## Conditions studied

- Pancreas Cancer

## Interventions

- **RADIATION:** 10 Gy Low-KV IORT
- **RADIATION:** 15 Gy Low-KV IORT
- **RADIATION:** 20 GY Low-KV IORT

## Key facts

- **NCT ID:** NCT02599662
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2022-01
- **Final completion:** 2023-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2020-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02599662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02599662, "Intraoperative Radiation Therapy for Resectable Pancreas Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02599662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*